| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $15.36M | $10.01M | $25.55M | $1.38M | $30.29M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $318.09M | $382.48M | $398.55M | $300.66M | $367.73M |
| R&D | $261.38M | $319.09M | $330.02M | $246.35M | $172.65M |
| SG&A | $56.71M | $76.59M | $74.95M | $65.98M | $57.39M |
| Operating Income | -$302.74M | -$372.47M | -$373.00M | -$299.27M | -$364.70M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$276.48M | -$337.71M | -$341.97M | -$290.51M | -$363.87M |
| EPS (basic) | -1.6100 | -2.3600 | -2.7900 | -2.5900 | -3.8200 |
| EPS (diluted) | -1.6100 | -2.3600 | -2.7900 | -2.5900 | -3.8200 |
| Shares (diluted) | – | – | – | $112.23M | $95.14M |